Skip to main content

Table 3 Cognitive and Psychological Assessments and Acetylcholinesterase Activity

From: Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease

  Baseline 12 weeks p-value (12 weeks vs. baseline)
MMSE 19.62 ± 4.71 20.29 ± 4.66 0.001*
FAST 4.24 ± 0.83 4.14 ± 0.85 0.16
ADCS-ADL 63.14 ± 8.6 63.29 ± 8.17 0.48
GDS 2.76 ± 1.09 2.86 ± 1.11 0.16
AChE activity (IU/L) 276.81 ± 56.28 159.81 ± 60.25 < 0.001*
  1. Paired sample t-test: *p < 0.05
  2. AChE Acetylcholinesterase, ADCS-ADL Alzheimer’s Disease Cooperative Study Activities of Daily Living, FAST Functional Assessment Staging, GDS Geriatric Depression Scale, MMSE Mini-Mental State Examination